A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Smoking isn’t just a lung issue, it’s a whole-body problem. The same toxic chemicals that damage the lungs also damage the bladder, pancreas, stomach, liver, mouth, and throat.

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.

March is Colorectal Cancer Awareness Month and an ideal time to focus on the third most common cancer in the U.S. Many people know the importance of ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

Extensive toxicological and epidemiological research has shown that these carcinogens cause DNA damage, mutational signatures ...

Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United States.

Cancer is the No. 1 cause of line-of-duty deaths among firefighters, who are 9% more likely than the general population to be ...